Why Compare 1.7mg Wegovy Price Against Mounjaro?
1.7mg Wegovy Price vs Mounjaro: Understanding Your Options
When evaluating 1.7mg Wegovy price against Mounjaro alternatives, you're comparing two distinct mechanisms of action for weight management. Wegovy contains semaglutide, a GLP-1 receptor agonist, whilst Mounjaro utilises tirzepatide, which targets both GLP-1 and GIP receptors. The 1.7mg Wegovy price of £139.99 represents weeks 13-16 of your dose escalation protocol, positioning you one step away from the 2.4mg maintenance dose. This stage often coincides with accelerated results as your body adapts to higher semaglutide concentrations.
Mounjaro follows a different dosing schedule, starting at 2.5mg and escalating through 5mg, 7.5mg, 10mg, 12.5mg, to a maximum 15mg maintenance dose over 20 weeks minimum. While direct price comparisons vary depending on your current Mounjaro dose, the 1.7mg Wegovy price offers a known pathway to maintenance at 2.4mg weekly. Both treatments require prescription through clinical assessment and must be used alongside a reduced-calorie diet and increased physical activity. Your prescriber can evaluate which mechanism suits your individual response pattern and lifestyle requirements.
1.7mg Wegovy Price: Bundle Savings and Checkout Codes
The single 1.7mg Wegovy price stands at £139.99, but our Elevate Duo bundle combining 1.7mg and 2.4mg pens costs £369.99 with discount codes applied at checkout. This bundle strategy ensures continuity as you transition from penultimate to maintenance dosing without additional ordering delays. Returning customers use code DOSE25 at checkout, while new customers apply FIRST40 to access these competitive pricing structures. The Consistency 1.7mg bundle provides two identical 1.7mg pens for £309.99, suitable if your prescriber recommends extending this dose phase.
For comprehensive progression planning, our Elevate Trio bundle includes 1mg, 1.7mg, and 2.4mg pens for £499.99, covering your final three dose escalations in one order. Bundle purchases provide convenience through fewer orders and Reliable Supply continuity, particularly important as you approach maintenance therapy. The 1.7mg Wegovy price within these bundles reflects the same clinical assessment and prescriber review process, ensuring each pen is appropriately prescribed for your weight management journey. All prices include our commitment to next-day cold-chain delivery once prescriber approval is confirmed.
Clinical Evidence: 1.7mg Wegovy Price Justified by STEP Trial Data
The 1.7mg Wegovy price reflects substantial clinical investment demonstrated through the STEP trial programme. In STEP 1, participants using Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks compared to 2.4% with placebo (Wilding et al., NEJM, 2021). The 1.7mg dose represents a critical escalation point where many patients begin experiencing enhanced appetite suppression and satiety signals. STEP 5 data showed sustained weight loss of approximately 15.2% at two years, supporting the value proposition behind continued treatment investment.
The SELECT cardiovascular outcomes trial demonstrated a 20% reduction in major cardiovascular events (HR 0.80) among participants taking semaglutide, potentially justifying the 1.7mg Wegovy price through broader health benefits. However, individual responses vary, and weight management remains a long-term commitment requiring consistent treatment adherence. These clinical outcomes inform prescriber recommendations when comparing Wegovy's evidence base against Mounjaro's trial data, though direct head-to-head comparisons aren't available due to different trial designs.
How Wegovy Works: Understanding Your 1.7mg Wegovy Price Investment
Your 1.7mg Wegovy price investment targets GLP-1 receptors throughout your body, mimicking natural incretin hormones that regulate appetite and glucose metabolism. Semaglutide enhances insulin secretion when glucose levels rise, delays gastric emptying to promote satiety, and directly influences hypothalamic appetite centres in your brain. At the 1.7mg dose level, these mechanisms typically produce noticeable changes in food cravings and portion satisfaction compared to earlier escalation phases. The once-weekly injection schedule maintains consistent semaglutide levels, supporting sustained appetite regulation throughout each dosing interval. This biological understanding helps justify the 1.7mg Wegovy price as targeted pharmaceutical intervention rather than simple appetite suppression, requiring prescription-only medicine classification and clinical oversight.
Ordering Process: Accessing Your 1.7mg Wegovy Price Quote
Securing your 1.7mg Wegovy price begins with our three-minute online clinical assessment, evaluating your weight management history, current medications, and treatment goals. Our prescribers review applications within standard three working days, or express 24-hour service for urgent requirements, ensuring appropriate clinical oversight before dispensing. Once approved, we dispatch your 1.7mg Wegovy via next-day delivery using temperature-controlled cold-chain logistics to maintain pharmaceutical integrity. The assessment process considers your progression through earlier Wegovy doses or transition from alternative treatments like Mounjaro, ensuring continuity of care. Our GPhC-registered pharmacy status (#9012878) ensures compliance with UK dispensing regulations while maintaining competitive pricing structures through efficient online operations.
Storage and Practical Considerations: 1.7mg Wegovy Price vs Mounjaro
The 1.7mg Wegovy price includes FlexTouch pen technology with superior storage flexibility compared to Mounjaro's requirements. Wegovy tolerates up to six weeks at room temperature below 30°C once removed from refrigeration, whilst Mounjaro permits only 21 days, making Wegovy more suitable for travel or workplace storage. Both treatments require initial refrigeration between 2-8°C and single-use pen replacement weekly, but Wegovy's extended ambient storage window provides practical advantages worth considering alongside pure price comparisons. The pre-filled FlexTouch design eliminates preparation complexity, though proper injection technique training remains essential for optimal absorption and treatment efficacy. These practical factors contribute to treatment adherence and long-term success, potentially influencing the real-world value of your 1.7mg Wegovy price investment.
Transitioning to Maintenance: Beyond 1.7mg Wegovy Price Planning
The 1.7mg Wegovy price represents your penultimate investment before reaching 2.4mg maintenance therapy, requiring forward planning for continued treatment success. Most patients spend four weeks at 1.7mg before escalating to 2.4mg, though your prescriber may extend this phase based on tolerance and response patterns. Our Elevate Duo bundle anticipates this transition, providing both doses for seamless progression without treatment interruption. The newly approved 7.2mg Wegovy dose offers future escalation potential for patients requiring enhanced intervention, though this remains unavailable at EverydayMeds pending supply arrangements.
Long-term maintenance planning becomes crucial at this stage, as STEP 1 extension data showed patients regained approximately two-thirds of lost weight within one year of stopping treatment. The 1.7mg Wegovy price therefore represents ongoing rather than temporary investment, requiring sustainable financial and lifestyle commitment. Weight management demands long-term pharmaceutical support combined with maintained dietary and exercise modifications for optimal outcomes. Planning your maintenance strategy while at 1.7mg allows informed decision-making about continued treatment versus alternative interventions.
Start Your Weight Management Journey Today
Compare your 1.7mg Wegovy price options against Mounjaro alternatives through our comprehensive clinical assessment, with both treatments available from our GPhC-registered pharmacy (#9012878). New customers apply discount code FIRST40 at checkout, while returning customers use DOSE25 to access competitive pricing on single pens or convenience bundles. Our prescribers evaluate your individual circumstances to recommend the most appropriate prescription-only medicine for your weight management goals. Visit https://everydaymeds.co.uk/collections/weight-loss to begin your clinical assessment and secure next-day delivery of your chosen treatment. Both Wegovy and Mounjaro represent evidence-based pharmaceutical interventions requiring ongoing commitment alongside lifestyle modifications for sustainable weight management success. Expert clinical support ensures safe, effective treatment tailored to your individual needs and circumstances.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
